Diagnostics company bioMerieux (PARIS:BIM) has received 510(k) clearance from the U.S. Food and Drug Administration for a test to detect and screen for methicillin-resistant staphylococcus, more ...

Precision medicine relies on biomarker testing to match therapies to specific cancers, yet many patients remain untested due ...

Molecular and genetic testing has become a game-changer in brain tumor care—shaping diagnosis, guiding treatments and opening ...

After years as a surgeon, Dr. Lishan Aklog now leads Lucid Diagnostics, a subsidiary of Pavmed, as it advances its unique ...

Get key insights from Insight Molecular Diagnostics' Q3 2025 earnings call—FDA progress, $1B market outlook, and innovations in transplant testing.

The Galleri test, by American company GRAIL, can detect over 50 types of cancerous DNA with a simple blood test. How the cancer screening test works.

SEATTLE — Molecular testing has been widely integrated into mainstream healthcare, and its use is increasing in dermatology. It can help differentiate between skin conditions, for example, as some ...

CT screening for lung cancer could save countless lives, but low participation rates have led to some eyebrow-raising proposals. Molecular methods, touted by those with a vested interest, promise to ...

Next on tap for Meridian Bioscience‘s (NASDAQ:VIVO) illumigene molecular diagnostic testing platform is a test for Mycoplasma pneumonia, an infection of the lungs. The illumigene Mycoplasma test is ...

Molecular and genetic testing has become a game-changer in brain tumour care - shaping diagnosis, guiding treatments and opening doors to new therapies.

BD’s new MiniDraw diagnostic devices could let pharmacists—and, one day, maybe patients—manage blood testing needs and monitor health conditions. BD received its FDA authorizations for two blood draw ...

Researchers at the US Centers for Disease Control and Prevention (CDC) have identified a few instances of asymptomatic human ...